News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Luis Raez: 3 INDs Approved for Patients with HER2 Mutations and Lung Cancer
Luis E. Raez/X
Aug 1, 2025, 16:21

Luis Raez: 3 INDs Approved for Patients with HER2 Mutations and Lung Cancer

Luis Raez, Medical Director and Chief Scientific Officer at Memorial Cancer Institute, shared a post on X:

“I want to give thanks to the FDA, at Memorial Cancer Institute we got today 3 INDs approved at the same time for patients with HER2 mutations and lung cancer to start zongertinib! If we can continue working this way we can benefit a lot of patients.”

Luis Raez

More posts featuring Luis E. Raez.

cancer FDA Luis Raez Lung cancer Memorial Cancer Institute OncoDaily Oncology
Special Coverage
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts
Radiotherapy
Aug 21, 2025, 12:31
New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test
Opinion
Aug 21, 2025, 12:03
UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH
Insight
Aug 21, 2025, 11:16
Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients
Voices
Aug 21, 2025, 11:15
Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...